Klin Farmakol Farm. 2012;26(2):93-97

Daily analgesics, their risks and prospects for development

Milan Kriška

Ústav farmakológie a klinickej farmakológie Lekárskej fakulty Univerzity Komenského, Bratislava

Despite existing WHO's schemes and professional societies' schemes, pharmacotherapy of pain, in addition to high consumption of analgesics,

remains one of the crucial problems of modern medicine due to drug-induced risks. The aim of the paper was to present an opinion on

the role of non-steroidal anti-inflammatory drugs (NSAIDs) and other daily analgesics in relation to other analgesics. Given the low degree

of critical thought of patients as well as health care professionals concerning the selection and use of analgesics, an opinion is required on

the risk of pharmacotherapy with analgesics in everyday clinical practice, also with respect to an increasing risk of developing unexpected

interactions. Because of the topic's complexity in terms of its extent and content and due to inconsistency in evaluating NSAIDs, we shall

confine ourselves, at the suggestion of the Editorial Board, to basic developmental trends with an emphasis on assessing the benefits and risks.

Keywords: analgesics for daily use, NSAIDs, analgesics risk, analgesics innovatious

Published: July 31, 2012  Show citation